Contract service agreement to generate induced pluripotent stem cells (iPSCs)Contract Service Agreement • March 17th, 2022
Contract Type FiledMarch 17th, 2022The National Institutes of Health Center for Regenerative Medicine has awarded Lonza a contract to generate induced pluripotent stem cells (iPSCs) for research purposes.